Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | E2F4 |
| Upstream (Parents) |
|---|
| (<<) ADAMTS7 → E2F4 |
| (<<) AQP3 → E2F4 |
| (<<) ATF2 → E2F4 |
| (<<) CASP5 → E2F4 |
| (<<) CCNE1 → E2F4 |
| (<<) CD4 → E2F4 |
| (<<) DPH2 → E2F4 |
| (<<) EIF2AK2 → E2F4 |
| (<<) ELF1 → E2F4 |
| (<<) FGFR2 → E2F4 |
| (<<) HSPA4 → E2F4 |
| (<<) KRAS → E2F4 |
| (<<) MAP2K4 → E2F4 |
| (<<) MPP1 → E2F4 |
| (<<) NFATC3 → E2F4 |
| (<<) PITPNC1 → E2F4 |
| (<<) PKIA → E2F4 |
| (<<) PPP1R3D → E2F4 |
| (<<) PTGS1 → E2F4 |
| (<<) RAD51L3 → E2F4 |
| (<<) RPIA → E2F4 |
| (<<) SLC5A1 → E2F4 |
| (<<) SMAD5 → E2F4 |
| (<<) SOS2 → E2F4 |
| (<<) TRAF1 → E2F4 |
| Downstream (Children) |
|---|
| E2F4 → AREG (>>) |
| E2F4 → HCN2 (>>) |
| E2F4 → PLA2R1 (>>) |
